Search Results - "Song, Qingxuan"
-
1
Integration of the Transcriptome and Genome-Wide Landscape of BRD2 and BRD4 Binding Motifs Identifies Key Superenhancer Genes and Reveals the Mechanism of Bet Inhibitor Action in Rheumatoid Arthritis Synovial Fibroblasts
Published in The Journal of immunology (1950) (15-01-2021)“…Fibroblast-like synoviocytes (FLS), one of the main cell types of the rheumatoid arthritis (RA) synovium, possess phenotypic and molecular characteristics of…”
Get full text
Journal Article -
2
Transcriptomic profiling of programmed cell death 1 (PD-1) expressing T cells in early rheumatoid arthritis identifies a decreased CD4 + PD-1 + signature post-treatment
Published in Scientific reports (17-02-2023)“…Programmed cell death protein 1 (PD-1)-expressing T cells are expanded in individuals with established rheumatoid arthritis (RA). However, little is known…”
Get full text
Journal Article -
3
Pooled segregant sequencing reveals genetic determinants of yeast pseudohyphal growth
Published in PLoS genetics (01-08-2014)“…The pseudohyphal growth response is a dramatic morphological transition and presumed foraging mechanism wherein yeast cells form invasive and surface-spread…”
Get full text
Journal Article -
4
Guselkumab induces robust reduction in acute phase proteins and type 17 effector cytokines in active psoriatic arthritis: results from phase 3 trials
Published in Rheumatic & musculoskeletal diseases open (01-05-2021)“…ObjectiveTo investigate serum protein expression in participants with psoriatic arthritis (PsA) and changes after guselkumab treatment.MethodsParticipants with…”
Get full text
Journal Article -
5
Guselkumab Modulates Differentially Expressed Genes in Blood of Patients With Psoriatic Arthritis: Results from Two Phase 3, Randomized, Placebo-Controlled Trials
Published in ACR open rheumatology (01-09-2023)“…To evaluate gene expression in blood of patients with psoriatic arthritis (PsA) versus healthy controls and identify changes associated with guselkumab…”
Get full text
Journal Article -
6
An Overview of Autophagy and Yeast Pseudohyphal Growth: Integration of Signaling Pathways during Nitrogen Stress
Published in Cells (04-07-2012)“…The budding yeast Saccharomyces cerevisiae responds to nutritional stress through the regulated activities of signaling pathways mediating autophagy and other…”
Get full text
Journal Article Book Review -
7
-
8
A large-scale complex haploinsufficiency-based genetic interaction screen in Candida albicans: analysis of the RAM network during morphogenesis
Published in PLoS genetics (01-04-2011)“…The morphogenetic transition between yeast and filamentous forms of the human fungal pathogen Candida albicans is regulated by a variety of signaling pathways…”
Get full text
Journal Article -
9
LncRNA XIST regulates breast cancer stem cells by activating proinflammatory IL-6/STAT3 signaling
Published in Oncogene (02-05-2023)“…Aberrant expression of XIST, a long noncoding RNA (lncRNA) initiating X chromosome inactivation (XCI) in early embryogenesis, is a common feature of breast…”
Get full text
Journal Article -
10
Rheumatoid arthritis macrophages are primed for inflammation and display bioenergetic and functional alterations
Published in Rheumatology (Oxford, England) (05-07-2023)“…Abstract Objectives Myeloid cells with a monocyte/macrophage phenotype are present in large numbers in the RA joint, significantly contributing to disease;…”
Get full text
Journal Article -
11
Abstract 2611: A crowdsourcing-based clinical trial information curation and searching system
Published in Cancer research (Chicago, Ill.) (01-07-2017)“…Abstract Targeted cancer therapies based on actionable mutations identified are the future of cancer treatment. Besides those approved by the Food and Drug…”
Get full text
Journal Article -
12
Abstract 5357: OncoGxSelectTM - a beneficial supplement to comprehensive cancer genetic test
Published in Cancer research (Chicago, Ill.) (01-07-2017)“…Abstract Genetic profiling of tumor has been widely accepted both in oncology research and clinical field. However, clinical doctors are sometimes overwhelmed…”
Get full text
Journal Article -
13
P273 Ustekinumab and guselkumab treatment results in differences in serum IL-17A, IL-17F and CRP levels in PsA patients: a comparison from ustekinumab Phase 3 and guselkumab Phase 2 programmes
Published in Rheumatology (Oxford, England) (01-04-2020)“…Abstract Background Ustekinumab (UST) is a monoclonal antibody (mAb) that binds the p40 epitope which is shared by IL-12 and IL-23, whereas guselkumab (GUS) is…”
Get full text
Journal Article -
14
-
15
Genetic and Molecular Distinctions Between Axial Psoriatic Arthritis and Radiographic Axial Spondyloarthritis: Post Hoc Analyses from Four Phase 3 Clinical Trials
Published in Advances in therapy (01-05-2023)“…Introduction Emerging evidence suggests psoriatic arthritis (PsA) with axial involvement (axPsA) and radiographic axial spondyloarthritis (r-axSpA)…”
Get full text
Journal Article -
16
Abstract 3633: OncoGxOneTM - an advanced genomic test for precision cancer treatment
Published in Cancer research (Chicago, Ill.) (15-07-2016)“…Abstract The fundamental cause of cancer is the aberration of genes that control cell proliferation and apoptosis. With the rapid advancement of genomic…”
Get full text
Journal Article -
17
Cancer classification in the genomic era: five contemporary problems
Published in Human genomics (19-10-2015)“…Classification is an everyday instinct as well as a full-fledged scientific discipline. Throughout the history of medicine, disease classification is central…”
Get full text
Journal Article -
18
Abstract 3579: RegCAR-TTM: Enabling next-generation CAR-T therapy
Published in Cancer research (Chicago, Ill.) (01-07-2018)“…Abstract Chimeric Antigen Receptor (CAR) T-Cell Therapy has been emerging as a means of powerful cancer immunotherapy with its exceptional therapeutic…”
Get full text
Journal Article -
19
The Phase 2 CARTITUDE-2 Trial: Updated Efficacy and Safety of Ciltacabtagene Autoleucel in Patients with Multiple Myeloma and 1-3 Prior Lines of Therapy (Cohort A) and with Early Relapse after First Line Treatment (Cohort B)
Published in Blood (02-11-2023)“…Introduction: CARTITUDE-2 (NCT04133636) is a phase 2, multicohort study evaluating the safety and efficacy of ciltacabtagene autoleucel (cilta-cel), an…”
Get full text
Journal Article -
20
MM-505 Efficacy and Safety of Ciltacabtagene Autoleucel ± Lenalidomide Maintenance in Newly Diagnosed Multiple Myeloma With Suboptimal Response to Frontline Autologous Stem Cell Transplant: CARTITUDE-2 Cohort D
Published in Clinical lymphoma, myeloma and leukemia (01-09-2024)“…CARTITUDE-2 is a phase 2 multicohort study evaluating ciltacabtagene autoleucel (cilta-cel), including cilta-cel ± lenalidomide maintenance in patients with…”
Get full text
Journal Article